NovaGo Therapeutics
Founded 2015 · $30.0M raised
- Founded
- 2015
- Website
- novagotherapeutics.com
- Total Funding
- $30.0M
- Last Round
- $30.0M Series BSep 2026
- Rounds
- 1
About
Swiss clinical-stage biotech company developing human antibody therapeutics that target nerve growth and regeneration for spinal cord injury and ischemic stroke.
Summary
NovaGo Therapeutics is a Biotech company, founded in 2015. It has raised $30.0M in total across 1 round, most recently a $30.0M Series B round in Sep 2026.
Funding History
Sep 2026
Similar Companies
China's leading blood products manufacturer
One of the world's largest contract research organizations (CROs), providing end-to-end clinical ...
Simtra provides pharmaceutical and biotech clients development and manufacturing services for ste...
IVI-RMA provides fertility treatments and patient-centered reproductive care, combining research,...
Specialty pharmaceutical company
inVentiv Health merged with INC Research to form Syneos Health, integrating clinical and commerci...
Your company? Embed this profile
Add the live badge to your site — it stays current as your funding data updates.
<a href="https://indexed.vc/companies/novago-therapeutics"><img src="https://indexed.vc/api/badge/company/novago-therapeutics" alt="NovaGo Therapeutics on Indexed.vc" width="260" height="76" /></a>